APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bacille Calmette-Guerin Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bacille Calmette-Guerin Vaccine Market Analysis and Forecast 2026-2032

29 December 2025196 pages

Choose your research edition.

Industry ResearchBacille Calmette-Guerin Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Bacille Calmette-Guerin Vaccine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Bacille Calmette-Guerin Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bacille Calmette-Guerin Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Bacille Calmette-Guerin Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Bacille Calmette-Guerin Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Bacille Calmette-Guerin Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bacille Calmette-Guerin Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bacille Calmette-Guerin Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bacille Calmette-Guerin Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Bacille Calmette-Guerin Vaccine include China National Biotec, Merck, Taj Pharmaceuticals, Serum Institute of India, Queen Saovabha Mem. Inst, Microgen, Japan BCG Lab, IVAC – Institute of Vaccines and Medical Biologicals and GreenSignal Bio Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Bacille Calmette-Guerin Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bacille Calmette-Guerin Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Bacille Calmette-Guerin Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bacille Calmette-Guerin Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bacille Calmette-Guerin Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Bacille Calmette-Guerin Vaccine sales, projected growth trends, production technology, application and end-user industry.

Bacille Calmette-Guerin Vaccine Segment by Company

China National Biotec

Merck

Taj Pharmaceuticals

Serum Institute of India

Queen Saovabha Mem. Inst

Microgen

Japan BCG Lab

IVAC – Institute of Vaccines and Medical Biologicals

GreenSignal Bio Pharma

Biomed Lublin

BioFarma

Ataulpho de Paiva

AJ Vaccines

Bacille Calmette-Guerin Vaccine Segment by Type

Immune Vaccine

Therapy Vaccine

Bacille Calmette-Guerin Vaccine Segment by Application

Self-Procurement

UNICEF

Other

Bacille Calmette-Guerin Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacille Calmette-Guerin Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bacille Calmette-Guerin Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacille Calmette-Guerin Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Bacille Calmette-Guerin Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Bacille Calmette-Guerin Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bacille Calmette-Guerin Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bacille Calmette-Guerin Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immune Vaccine Major Manufacturers Table 3. Therapy Vaccine Major Manufacturers Table 4. Global Bacille Calmette-Guerin Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Self-Procurement Major Manufacturers Table 6. UNICEF Major Manufacturers Table 7. Other Major Manufacturers Table 8. Bacille Calmette-Guerin Vaccine Industry Trends Table 9. Bacille Calmette-Guerin Vaccine Industry Drivers Table 10. Bacille Calmette-Guerin Vaccine Industry Opportunities and Challenges Table 11. Bacille Calmette-Guerin Vaccine Industry Restraints Table 12. Global Bacille Calmette-Guerin Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Bacille Calmette-Guerin Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Bacille Calmette-Guerin Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global Bacille Calmette-Guerin Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Bacille Calmette-Guerin Vaccine Sales by Region (2021-2026) & (K Units) Table 19. Global Bacille Calmette-Guerin Vaccine Sales by Region (2027-2032) & (K Units) Table 20. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2021-2026) Table 21. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2027-2032) Table 22. Global Bacille Calmette-Guerin Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Bacille Calmette-Guerin Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Bacille Calmette-Guerin Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Bacille Calmette-Guerin Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Bacille Calmette-Guerin Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Bacille Calmette-Guerin Vaccine Manufacturers, Product Type & Application Table 30. Global Bacille Calmette-Guerin Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Bacille Calmette-Guerin Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Bacille Calmette-Guerin Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Bacille Calmette-Guerin Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Bacille Calmette-Guerin Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global Bacille Calmette-Guerin Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (K Units) Table 40. Global Bacille Calmette-Guerin Vaccine Sales by Type (2027-2032) & (K Units) Table 41. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2021-2026) Table 42. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2027-2032) Table 43. Global Bacille Calmette-Guerin Vaccine Price by Type (2021-2026) & (US$/Unit) Table 44. Global Bacille Calmette-Guerin Vaccine Price by Type (2027-2032) & (US$/Unit) Table 45. Global Bacille Calmette-Guerin Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Bacille Calmette-Guerin Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Bacille Calmette-Guerin Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global Bacille Calmette-Guerin Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Bacille Calmette-Guerin Vaccine Sales by Application (2027-2032) & (K Units) Table 53. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Bacille Calmette-Guerin Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Bacille Calmette-Guerin Vaccine Price by Application (2027-2032) & (US$/Unit) Table 57. China National Biotec Company Information Table 58. China National Biotec Business Overview Table 59. China National Biotec Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. China National Biotec Bacille Calmette-Guerin Vaccine Product Portfolio Table 61. China National Biotec Recent Development Table 62. Merck Company Information Table 63. Merck Business Overview Table 64. Merck Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Merck Bacille Calmette-Guerin Vaccine Product Portfolio Table 66. Merck Recent Development Table 67. Taj Pharmaceuticals Company Information Table 68. Taj Pharmaceuticals Business Overview Table 69. Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Product Portfolio Table 71. Taj Pharmaceuticals Recent Development Table 72. Serum Institute of India Company Information Table 73. Serum Institute of India Business Overview Table 74. Serum Institute of India Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Serum Institute of India Bacille Calmette-Guerin Vaccine Product Portfolio Table 76. Serum Institute of India Recent Development Table 77. Queen Saovabha Mem. Inst Company Information Table 78. Queen Saovabha Mem. Inst Business Overview Table 79. Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Product Portfolio Table 81. Queen Saovabha Mem. Inst Recent Development Table 82. Microgen Company Information Table 83. Microgen Business Overview Table 84. Microgen Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Microgen Bacille Calmette-Guerin Vaccine Product Portfolio Table 86. Microgen Recent Development Table 87. Japan BCG Lab Company Information Table 88. Japan BCG Lab Business Overview Table 89. Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Japan BCG Lab Bacille Calmette-Guerin Vaccine Product Portfolio Table 91. Japan BCG Lab Recent Development Table 92. IVAC – Institute of Vaccines and Medical Biologicals Company Information Table 93. IVAC – Institute of Vaccines and Medical Biologicals Business Overview Table 94. IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Product Portfolio Table 96. IVAC – Institute of Vaccines and Medical Biologicals Recent Development Table 97. GreenSignal Bio Pharma Company Information Table 98. GreenSignal Bio Pharma Business Overview Table 99. GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Product Portfolio Table 101. GreenSignal Bio Pharma Recent Development Table 102. Biomed Lublin Company Information Table 103. Biomed Lublin Business Overview Table 104. Biomed Lublin Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Biomed Lublin Bacille Calmette-Guerin Vaccine Product Portfolio Table 106. Biomed Lublin Recent Development Table 107. BioFarma Company Information Table 108. BioFarma Business Overview Table 109. BioFarma Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. BioFarma Bacille Calmette-Guerin Vaccine Product Portfolio Table 111. BioFarma Recent Development Table 112. Ataulpho de Paiva Company Information Table 113. Ataulpho de Paiva Business Overview Table 114. Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Product Portfolio Table 116. Ataulpho de Paiva Recent Development Table 117. AJ Vaccines Company Information Table 118. AJ Vaccines Business Overview Table 119. AJ Vaccines Bacille Calmette-Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. AJ Vaccines Bacille Calmette-Guerin Vaccine Product Portfolio Table 121. AJ Vaccines Recent Development Table 122. North America Bacille Calmette-Guerin Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Bacille Calmette-Guerin Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (K Units) Table 125. North America Bacille Calmette-Guerin Vaccine Sales by Type (2027-2032) & (K Units) Table 126. North America Bacille Calmette-Guerin Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 127. North America Bacille Calmette-Guerin Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 128. North America Bacille Calmette-Guerin Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Bacille Calmette-Guerin Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (K Units) Table 131. North America Bacille Calmette-Guerin Vaccine Sales by Application (2027-2032) & (K Units) Table 132. North America Bacille Calmette-Guerin Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 133. North America Bacille Calmette-Guerin Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 134. North America Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Bacille Calmette-Guerin Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 138. North America Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026) & (K Units) Table 139. North America Bacille Calmette-Guerin Vaccine Sales by Country (2027-2032) & (K Units) Table 140. North America Bacille Calmette-Guerin Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 141. North America Bacille Calmette-Guerin Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 142. United States Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 143. Canada Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 144. Europe Bacille Calmette-Guerin Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 145. Europe Bacille Calmette-Guerin Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 146. Europe Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (K Units) Table 147. Europe Bacille Calmette-Guerin Vaccine Sales by Type (2027-2032) & (K Units) Table 148. Europe Bacille Calmette-Guerin Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 149. Europe Bacille Calmette-Guerin Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 150. Europe Bacille Calmette-Guerin Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 151. Europe Bacille Calmette-Guerin Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 152. Europe Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (K Units) Table 153. Europe Bacille Calmette-Guerin Vaccine Sales by Application (2027-2032) & (K Units) Table 154. Europe Bacille Calmette-Guerin Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 155. Europe Bacille Calmette-Guerin Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Europe Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Europe Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Europe Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Europe Bacille Calmette-Guerin Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 160. Europe Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026) & (K Units) Table 161. Europe Bacille Calmette-Guerin Vaccine Sales by Country (2027-2032) & (K Units) Table 162. Europe Bacille Calmette-Guerin Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 163. Europe Bacille Calmette-Guerin Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 164. Germany Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 165. France Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 166. U.K. Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 167. Italy Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 168. Netherlands Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 169. Nordic Countries Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 170. China Bacille Calmette-Guerin Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 171. China Bacille Calmette-Guerin Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 172. China Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (K Units) Table 173. China Bacille Calmette-Guerin Vaccine Sales by Type (2027-2032) & (K Units) Table 174. China Bacille Calmette-Guerin Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 175. China Bacille Calmette-Guerin Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 176. China Bacille Calmette-Guerin Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 177. China Bacille Calmette-Guerin Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 178. China Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (K Units) Table 179. China Bacille Calmette-Guerin Vaccine Sales by Application (2027-2032) & (K Units) Table 180. China Bacille Calmette-Guerin Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 181. China Bacille Calmette-Guerin Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Bacille Calmette-Guerin Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Bacille Calmette-Guerin Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (K Units) Table 185. Asia Bacille Calmette-Guerin Vaccine Sales by Type (2027-2032) & (K Units) Table 186. Asia Bacille Calmette-Guerin Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 187. Asia Bacille Calmette-Guerin Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 188. Asia Bacille Calmette-Guerin Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Bacille Calmette-Guerin Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (K Units) Table 191. Asia Bacille Calmette-Guerin Vaccine Sales by Application (2027-2032) & (K Units) Table 192. Asia Bacille Calmette-Guerin Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 193. Asia Bacille Calmette-Guerin Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Bacille Calmette-Guerin Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. Asia Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026) & (K Units) Table 199. Asia Bacille Calmette-Guerin Vaccine Sales by Country (2027-2032) & (K Units) Table 200. Asia Bacille Calmette-Guerin Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 201. Asia Bacille Calmette-Guerin Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Japan Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 203. South Korea Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 204. India Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 205. Australia Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 206. China Taiwan Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Bacille Calmette-Guerin Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Bacille Calmette-Guerin Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Bacille Calmette-Guerin Vaccine Sales by Type (2021-2026) & (K Units) Table 211. SAMEA Bacille Calmette-Guerin Vaccine Sales by Type (2027-2032) & (K Units) Table 212. SAMEA Bacille Calmette-Guerin Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 213. SAMEA Bacille Calmette-Guerin Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 214. SAMEA Bacille Calmette-Guerin Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Bacille Calmette-Guerin Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Bacille Calmette-Guerin Vaccine Sales by Application (2021-2026) & (K Units) Table 217. SAMEA Bacille Calmette-Guerin Vaccine Sales by Application (2027-2032) & (K Units) Table 218. SAMEA Bacille Calmette-Guerin Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 219. SAMEA Bacille Calmette-Guerin Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 220. SAMEA Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Bacille Calmette-Guerin Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 224. SAMEA Bacille Calmette-Guerin Vaccine Sales by Country (2021-2026) & (K Units) Table 225. SAMEA Bacille Calmette-Guerin Vaccine Sales by Country (2027-2032) & (K Units) Table 226. SAMEA Bacille Calmette-Guerin Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 227. SAMEA Bacille Calmette-Guerin Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 228. Brazil Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 229. Argentina Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 230. Chile Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 231. Colombia Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 232. Peru Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 234. Israel Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 235. UAE Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 236. Turkey Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 237. Iran Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 238. Egypt Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Bacille Calmette-Guerin Vaccine Distributors List Table 242. Bacille Calmette-Guerin Vaccine Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Bacille Calmette-Guerin Vaccine Image Figure 2. Global Bacille Calmette-Guerin Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bacille Calmette-Guerin Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immune Vaccine Image Figure 5. Therapy Vaccine Image Figure 6. Global Bacille Calmette-Guerin Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Bacille Calmette-Guerin Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Self-Procurement Image Figure 9. UNICEF Image Figure 10. Other Image Figure 11. Global Bacille Calmette-Guerin Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Bacille Calmette-Guerin Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global Bacille Calmette-Guerin Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global Bacille Calmette-Guerin Vaccine Sales (2021-2032) & (K Units) Figure 17. Global Bacille Calmette-Guerin Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Bacille Calmette-Guerin Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. Europe Bacille Calmette-Guerin Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. China Bacille Calmette-Guerin Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Bacille Calmette-Guerin Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Bacille Calmette-Guerin Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. Global Bacille Calmette-Guerin Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Bacille Calmette-Guerin Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Bacille Calmette-Guerin Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global Bacille Calmette-Guerin Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global Bacille Calmette-Guerin Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global Bacille Calmette-Guerin Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America Bacille Calmette-Guerin Vaccine Revenue Share by Type (2021-2032) Figure 40. North America Bacille Calmette-Guerin Vaccine Sales Share by Type (2021-2032) Figure 41. North America Bacille Calmette-Guerin Vaccine Revenue Share by Application (2021-2032) Figure 42. North America Bacille Calmette-Guerin Vaccine Sales Share by Application (2021-2032) Figure 43. North America Bacille Calmette-Guerin Vaccine Revenue Share by Country (2021-2032) Figure 44. North America Bacille Calmette-Guerin Vaccine Sales Share by Country (2021-2032) Figure 45. Europe Bacille Calmette-Guerin Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe Bacille Calmette-Guerin Vaccine Sales Share by Type (2021-2032) Figure 47. Europe Bacille Calmette-Guerin Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe Bacille Calmette-Guerin Vaccine Sales Share by Application (2021-2032) Figure 49. Europe Bacille Calmette-Guerin Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe Bacille Calmette-Guerin Vaccine Sales Share by Country (2021-2032) Figure 51. China Bacille Calmette-Guerin Vaccine Revenue Share by Type (2021-2032) Figure 52. China Bacille Calmette-Guerin Vaccine Sales Share by Type (2021-2032) Figure 53. China Bacille Calmette-Guerin Vaccine Revenue Share by Application (2021-2032) Figure 54. China Bacille Calmette-Guerin Vaccine Sales Share by Application (2021-2032) Figure 55. Asia Bacille Calmette-Guerin Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia Bacille Calmette-Guerin Vaccine Sales Share by Type (2021-2032) Figure 57. Asia Bacille Calmette-Guerin Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia Bacille Calmette-Guerin Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Bacille Calmette-Guerin Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia Bacille Calmette-Guerin Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA Bacille Calmette-Guerin Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA Bacille Calmette-Guerin Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA Bacille Calmette-Guerin Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA Bacille Calmette-Guerin Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA Bacille Calmette-Guerin Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA Bacille Calmette-Guerin Vaccine Sales Share by Country (2021-2032) Figure 67. Bacille Calmette-Guerin Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Bacille Calmette-Guerin Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Immune Vaccine
  • Therapy Vaccine
Applications
  • Self-Procurement
  • UNICEF
  • Other
Companies covered
  • China National Biotec
  • Merck
  • Taj Pharmaceuticals
  • Serum Institute of India
  • Queen Saovabha Mem. Inst
  • Microgen
  • Japan BCG Lab
  • IVAC – Institute of Vaccines and Medical Biologicals
  • GreenSignal Bio Pharma
  • Biomed Lublin
  • BioFarma
  • Ataulpho de Paiva
  • AJ Vaccines

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bacille Calmette-Guerin Vaccine Market by Type
  3. 1.2.1 Global Bacille Calmette-Guerin Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immune Vaccine
  5. 1.2.3 Therapy Vaccine
  6. 1.3 Bacille Calmette-Guerin Vaccine Market by Application
  7. 1.3.1 Global Bacille Calmette-Guerin Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Self-Procurement
  9. 1.3.3 UNICEF
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Bacille Calmette-Guerin Vaccine Market Dynamics
  1. 2.1 Bacille Calmette-Guerin Vaccine Industry Trends
  2. 2.2 Bacille Calmette-Guerin Vaccine Industry Drivers
  3. 2.3 Bacille Calmette-Guerin Vaccine Industry Opportunities and Challenges
  4. 2.4 Bacille Calmette-Guerin Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Bacille Calmette-Guerin Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Bacille Calmette-Guerin Vaccine Revenue by Region
  3. 3.2.1 Global Bacille Calmette-Guerin Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bacille Calmette-Guerin Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Bacille Calmette-Guerin Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Bacille Calmette-Guerin Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Bacille Calmette-Guerin Vaccine Sales by Region
  9. 3.4.1 Global Bacille Calmette-Guerin Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Bacille Calmette-Guerin Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Bacille Calmette-Guerin Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Bacille Calmette-Guerin Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Bacille Calmette-Guerin Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Bacille Calmette-Guerin Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bacille Calmette-Guerin Vaccine Sales by Manufacturers
  6. 4.2.1 Global Bacille Calmette-Guerin Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Bacille Calmette-Guerin Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Bacille Calmette-Guerin Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Bacille Calmette-Guerin Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Bacille Calmette-Guerin Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Bacille Calmette-Guerin Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Bacille Calmette-Guerin Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Bacille Calmette-Guerin Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Bacille Calmette-Guerin Vaccine Tier 1, Tier 2, and Tier 3
5 Bacille Calmette-Guerin Vaccine Market by Type
  1. 5.1 Global Bacille Calmette-Guerin Vaccine Revenue by Type
  2. 5.1.1 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Bacille Calmette-Guerin Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Bacille Calmette-Guerin Vaccine Sales by Type
  6. 5.2.1 Global Bacille Calmette-Guerin Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bacille Calmette-Guerin Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Bacille Calmette-Guerin Vaccine Price by Type
6 Bacille Calmette-Guerin Vaccine Market by Application
  1. 6.1 Global Bacille Calmette-Guerin Vaccine Revenue by Application
  2. 6.1.1 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Bacille Calmette-Guerin Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Bacille Calmette-Guerin Vaccine Sales by Application
  6. 6.2.1 Global Bacille Calmette-Guerin Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Bacille Calmette-Guerin Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Bacille Calmette-Guerin Vaccine Price by Application
7 Company Profiles
  1. 7.1 China National Biotec
  2. 7.1.1 China National Biotec Company Information
  3. 7.1.2 China National Biotec Business Overview
  4. 7.1.3 China National Biotec Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 China National Biotec Bacille Calmette-Guerin Vaccine Product Portfolio
  6. 7.1.5 China National Biotec Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Bacille Calmette-Guerin Vaccine Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Taj Pharmaceuticals
  14. 7.3.1 Taj Pharmaceuticals Company Information
  15. 7.3.2 Taj Pharmaceuticals Business Overview
  16. 7.3.3 Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Product Portfolio
  18. 7.3.5 Taj Pharmaceuticals Recent Developments
  19. 7.4 Serum Institute of India
  20. 7.4.1 Serum Institute of India Company Information
  21. 7.4.2 Serum Institute of India Business Overview
  22. 7.4.3 Serum Institute of India Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Serum Institute of India Bacille Calmette-Guerin Vaccine Product Portfolio
  24. 7.4.5 Serum Institute of India Recent Developments
  25. 7.5 Queen Saovabha Mem. Inst
  26. 7.5.1 Queen Saovabha Mem. Inst Company Information
  27. 7.5.2 Queen Saovabha Mem. Inst Business Overview
  28. 7.5.3 Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Product Portfolio
  30. 7.5.5 Queen Saovabha Mem. Inst Recent Developments
  31. 7.6 Microgen
  32. 7.6.1 Microgen Company Information
  33. 7.6.2 Microgen Business Overview
  34. 7.6.3 Microgen Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Microgen Bacille Calmette-Guerin Vaccine Product Portfolio
  36. 7.6.5 Microgen Recent Developments
  37. 7.7 Japan BCG Lab
  38. 7.7.1 Japan BCG Lab Company Information
  39. 7.7.2 Japan BCG Lab Business Overview
  40. 7.7.3 Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Japan BCG Lab Bacille Calmette-Guerin Vaccine Product Portfolio
  42. 7.7.5 Japan BCG Lab Recent Developments
  43. 7.8 IVAC – Institute of Vaccines and Medical Biologicals
  44. 7.8.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information
  45. 7.8.2 IVAC – Institute of Vaccines and Medical Biologicals Business Overview
  46. 7.8.3 IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Product Portfolio
  48. 7.8.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments
  49. 7.9 GreenSignal Bio Pharma
  50. 7.9.1 GreenSignal Bio Pharma Company Information
  51. 7.9.2 GreenSignal Bio Pharma Business Overview
  52. 7.9.3 GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Product Portfolio
  54. 7.9.5 GreenSignal Bio Pharma Recent Developments
  55. 7.10 Biomed Lublin
  56. 7.10.1 Biomed Lublin Company Information
  57. 7.10.2 Biomed Lublin Business Overview
  58. 7.10.3 Biomed Lublin Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Biomed Lublin Bacille Calmette-Guerin Vaccine Product Portfolio
  60. 7.10.5 Biomed Lublin Recent Developments
  61. 7.11 BioFarma
  62. 7.11.1 BioFarma Company Information
  63. 7.11.2 BioFarma Business Overview
  64. 7.11.3 BioFarma Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 BioFarma Bacille Calmette-Guerin Vaccine Product Portfolio
  66. 7.11.5 BioFarma Recent Developments
  67. 7.12 Ataulpho de Paiva
  68. 7.12.1 Ataulpho de Paiva Company Information
  69. 7.12.2 Ataulpho de Paiva Business Overview
  70. 7.12.3 Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Product Portfolio
  72. 7.12.5 Ataulpho de Paiva Recent Developments
  73. 7.13 AJ Vaccines
  74. 7.13.1 AJ Vaccines Company Information
  75. 7.13.2 AJ Vaccines Business Overview
  76. 7.13.3 AJ Vaccines Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 AJ Vaccines Bacille Calmette-Guerin Vaccine Product Portfolio
  78. 7.13.5 AJ Vaccines Recent Developments
8 North America
  1. 8.1 North America Bacille Calmette-Guerin Vaccine Market Size by Type
  2. 8.1.1 North America Bacille Calmette-Guerin Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Bacille Calmette-Guerin Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Bacille Calmette-Guerin Vaccine Price by Type (2021-2032)
  5. 8.2 North America Bacille Calmette-Guerin Vaccine Market Size by Application
  6. 8.2.1 North America Bacille Calmette-Guerin Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Bacille Calmette-Guerin Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Bacille Calmette-Guerin Vaccine Price by Application (2021-2032)
  9. 8.3 North America Bacille Calmette-Guerin Vaccine Market Size by Country
  10. 8.3.1 North America Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Bacille Calmette-Guerin Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Bacille Calmette-Guerin Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Bacille Calmette-Guerin Vaccine Market Size by Type
  2. 9.1.1 Europe Bacille Calmette-Guerin Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Bacille Calmette-Guerin Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Bacille Calmette-Guerin Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Bacille Calmette-Guerin Vaccine Market Size by Application
  6. 9.2.1 Europe Bacille Calmette-Guerin Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Bacille Calmette-Guerin Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Bacille Calmette-Guerin Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Bacille Calmette-Guerin Vaccine Market Size by Country
  10. 9.3.1 Europe Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Bacille Calmette-Guerin Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Bacille Calmette-Guerin Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Bacille Calmette-Guerin Vaccine Market Size by Type
  2. 10.1.1 China Bacille Calmette-Guerin Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Bacille Calmette-Guerin Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Bacille Calmette-Guerin Vaccine Price by Type (2021-2032)
  5. 10.2 China Bacille Calmette-Guerin Vaccine Market Size by Application
  6. 10.2.1 China Bacille Calmette-Guerin Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Bacille Calmette-Guerin Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Bacille Calmette-Guerin Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bacille Calmette-Guerin Vaccine Market Size by Type
  2. 11.1.1 Asia Bacille Calmette-Guerin Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Bacille Calmette-Guerin Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Bacille Calmette-Guerin Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Bacille Calmette-Guerin Vaccine Market Size by Application
  6. 11.2.1 Asia Bacille Calmette-Guerin Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Bacille Calmette-Guerin Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Bacille Calmette-Guerin Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Bacille Calmette-Guerin Vaccine Market Size by Country
  10. 11.3.1 Asia Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Bacille Calmette-Guerin Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Bacille Calmette-Guerin Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bacille Calmette-Guerin Vaccine Market Size by Type
  2. 12.1.1 SAMEA Bacille Calmette-Guerin Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Bacille Calmette-Guerin Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Bacille Calmette-Guerin Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Bacille Calmette-Guerin Vaccine Market Size by Application
  6. 12.2.1 SAMEA Bacille Calmette-Guerin Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Bacille Calmette-Guerin Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Bacille Calmette-Guerin Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Bacille Calmette-Guerin Vaccine Market Size by Country
  10. 12.3.1 SAMEA Bacille Calmette-Guerin Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Bacille Calmette-Guerin Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Bacille Calmette-Guerin Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Bacille Calmette-Guerin Vaccine Value Chain Analysis
  2. 13.1.1 Bacille Calmette-Guerin Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Bacille Calmette-Guerin Vaccine Production Mode & Process
  6. 13.2 Bacille Calmette-Guerin Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Bacille Calmette-Guerin Vaccine Distributors
  9. 13.2.3 Bacille Calmette-Guerin Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst